NRX Pharmaceuticals Inc (NRXP) Stock Analysis

NRX Pharmaceuticals Inc (NRXP) is a publicly traded company in the HEALTHCARE sector. It trades at $4.62, carries a market capitalization of $160.13M. This page summarizes the public market data, fundamentals, and frequently asked questions for NRXP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.62
• Market Cap: $160.13M
• EPS: $-1.04
• 52-Week High: $4.86
• 52-Week Low: $1.62

Market Sentiment

NRX Pharmaceuticals Inc currently has a Bullish sentiment score of 0.43.

About NRX Pharmaceuticals Inc

NRx Pharmaceuticals, Inc. (NRXP) is a clinical-stage biopharmaceutical company headquartered in Wilmington, Delaware, dedicated to developing pioneering therapies for severe central nervous system disorders and respiratory diseases. The company is committed to addressing unmet medical needs through its proprietary technologies and innovative research, resulting in a promising pipeline that targets critical health challenges. As NRX advances its drug candidates through rigorous clinical trials...

GNG Research Analysis

GNG Research scores NRX Pharmaceuticals Inc (NRXP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NRXP.

Frequently Asked Questions

Does NRXP pay dividends?

NRX Pharmaceuticals Inc (NRXP) does not currently pay a regular dividend.

What is NRXP's market cap?

NRX Pharmaceuticals Inc (NRXP) has a market capitalization of $160.13M with a current stock price of $4.62.